Financhill
Sell
29

DOC Quote, Financials, Valuation and Earnings

Last price:
$20.02
Seasonality move :
2.48%
Day range:
$19.95 - $20.39
52-week range:
$17.45 - $23.26
Dividend yield:
6.02%
P/E ratio:
57.23x
P/S ratio:
5.02x
P/B ratio:
1.67x
Volume:
7.3M
Avg. volume:
4.9M
1-year change:
12.4%
Market cap:
$14B
Revenue:
$2.7B
EPS (TTM):
$0.35

Earnings Data

Next earnings date for DOC
Apr 25
2025
Most recent earnings per share
$0.01
Missed by $0.04
(Feb 3/2025)
Consensus Estimate
$0.05
(Feb 3/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

DOC Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
04/25/2025 Q1 $690.8M -- -- $0.05 --
02/03/2025 Q4 $692.2M $698M $0.01 $0.05 -$0.04
10/24/2024 Q3 $684.5M $700.4M $0.12 $0.05 $0.07
07/25/2024 Q2 $676.1M $695.5M $0.21 $0.09 $0.12
04/25/2024 Q1 $599.5M $606.6M $0.01 $0.05 -$0.04
02/08/2024 Q4 $554M $553.7M $0.13 $0.10 $0.03
10/30/2023 Q3 $543.5M $556.2M $0.12 $0.08 $0.04
08/03/2023 Q2 $536.3M $545.4M $0.09 $0.10 -$0.01
05/04/2023 Q1 $521.1M $525.7M $0.22 -- --
02/22/2023 Q4 -- $524.5M $0.01 -- --
11/03/2022 Q3 -- $520.4M $0.65 -- --
08/04/2022 Q2 -- $517.9M $0.13 -- --
05/04/2022 Q1 -- $498.4M $0.13 -- --
02/23/2022 Q4 -- $483.2M $0.05 -- --
11/05/2021 Q3 -- $481.5M $0.10 -- --
08/04/2021 Q2 -- $476.2M $0.51 -- --
05/05/2021 Q1 -- $455.3M $0.27 -- --
02/25/2021 Q4 -- $431.7M $0.27 -- --
11/06/2020 Q3 -- $423.6M -$0.12 -- --
08/06/2020 Q2 -- $408.6M $0.09 -- --
05/07/2020 Q1 -- $381.1M $0.54 -- --
02/26/2020 Q4 -- -$225.4M $0.09 -- --
11/06/2019 Q3 -- $538M -$0.09 -- --
08/07/2019 Q2 -- $491.6M -$0.03 -- --
05/01/2019 Q1 -- $436.2M $0.13 -- --
02/27/2019 Q4 -- -$213.5M $1.73 -- --
11/02/2018 Q3 -- $456M $0.21 -- --
08/02/2018 Q2 -- $469.6M $0.19 -- --
05/04/2018 Q1 -- $479.2M $0.08 -- --
02/28/2018 Q4 -- $443.3M -$0.13 -- --
11/03/2017 Q3 -- $454M -$0.02 -- --
08/03/2017 Q2 -- $458.9M $0.04 -- --
05/03/2017 Q1 -- $492.2M $0.97 -- --
02/24/2017 Q4 -- $539.9M $0.12 -- --
11/02/2016 Q3 -- $530.6M $0.32 -- --
08/03/2016 Q2 -- $538.3M $0.64 -- --
05/05/2016 Q1 -- $520.5M $0.25 -- --
02/29/2016 Q4 -- $65.6M -$1.29 -- --
11/06/2015 Q3 -- $657.5M $0.25 -- --
08/07/2015 Q2 -- $607.5M $0.36 -- --
05/07/2015 Q1 -- $610.8M -$0.52 -- --

Healthpeak Properties Earnings Questions

  • How Much did Healthpeak Properties Generate in Revenue Last Quarter?

    Healthpeak Properties reported $698M worth of top line sales in its most recent quarter.

  • Did Healthpeak Properties Beat Earnings Last Quarter?

    Healthpeak Properties announced earnings per share of $0.01 which represents a miss of analyst forecast a $0.05 per share.

  • Is Healthpeak Properties Profitable?

    Healthpeak Properties reported $421M that represents $0.60 per share over the last quarter.

  • What is the Analyst Consensus for Healthpeak Properties EPS Next Year?

    Healthpeak Properties's earnings are forecast to decrease from $0.36 per share to $0.21 per share next year representing a decrease of -40.74%.

  • When is Healthpeak Properties's Earnings Date?

    Healthpeak Properties's next earnings date is April 25, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Amazon Stock Still Worth Staking On?
Is Amazon Stock Still Worth Staking On?

Amazon.com Inc (NASDAQ: AMZN) posted one of its strongest years…

Is Palantir a Good Stock to Buy?
Is Palantir a Good Stock to Buy?

Palantir Technologies (PLTR) stock soared to its highest level in…

Why Is Sportradar Stock Going Up?
Why Is Sportradar Stock Going Up?

Sportradar (NASDAQ:SRAD) should be on your radar for a stock…

Stock Ideas

Buy
55
Is AAPL Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 36x

Buy
53
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Buy
51
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 40x

Alerts

Sell
50
RGC alert for Mar 22

Regencell Bioscience Holdings [RGC] is up 27.82% over the past day.

Sell
36
VMI alert for Mar 22

Valmont Industries [VMI] is down 12.54% over the past day.

Buy
61
ALNY alert for Mar 22

Alnylam Pharmaceuticals [ALNY] is up 11.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock